News
BRISBANE, Calif.--(BUSINESS WIRE)--Maverick Therapeutics, Inc., a private biopharmaceutical company pioneering conditionally active bispecific T cell targeted immunotherapies, today announced the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback